Omeprazole and Hip drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omeprazole (omeprazole) and Hip (rose hip). Common drug interactions include sinus congestion among females and rib fracture among males.

The phase IV clinical study analyzes what interactions people have when they take Omeprazole and Hip. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Hip?

Hip has active ingredients of rose hip. eHealthMe is studying from 473 Hip users. Check the latest studies of Hip.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

65 people who take Omeprazole and Hip together, and have interactions are studied.

What are the common drug interactions of Omeprazole and Hip, by gender? *:

female:

Sinus congestion (blockage of sinus)
Constipation
Abdominal discomfort
Angioedema (rapid swelling of the dermis)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back disorder
Back pain
Biliary cirrhosis primary (primary biliary cirrhosis (pbc) is a long-term liver disease that damages the small bile ducts in the liver. the build-up of bile damages the liver)
Breast enlargement
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

Rib fracture
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
Fatigue (feeling of tiredness)
Gait disturbance
Haemoglobin decreased
Headache (pain in head)
Joint injury
Muscle spasms (muscle contraction)
Muscular weakness (muscle weakness)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

What are the common drug interactions of Omeprazole and Hip, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Respiratory tract infection
Sinusitis (inflammation of sinus)

30-39:

Dysgeusia (disorder of the sense of taste)

40-49:

Hospitalisation
Injection site bruising
Nausea (feeling of having an urge to vomit)
Vomiting

50-59:

Gastritis (inflammation of stomach)
Gingival disorder (gum disease)
Haemorrhagic anaemia (anaemia due to excessive bleeding)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Herpes zoster
Hip fracture
Hypercholesterolaemia (high levels of cholesterol in the blood)
Hypertension (high blood pressure)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Impaired healing

60+:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)
Bladder pain
Hypoaesthesia (reduced sense of touch or sensation)
Localised infection (infection at the single location)
Nasopharyngitis (inflammation of the nasopharynx)
Protein total decreased
Asthenia (weakness)
Erythema (redness of the skin)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 15 people, 23.08%
Breast Cancer: 9 people, 13.85%
Osteoporosis (bones weak and more likely to break): 8 people, 12.31%
Hypersensitivity: 8 people, 12.31%
Osteopenia (a condition where bone mineral density is lower than normal): 7 people, 10.77%
High Blood Pressure: 7 people, 10.77%
High Blood Cholesterol: 7 people, 10.77%
Headache (pain in head): 7 people, 10.77%
Pain: 6 people, 9.23%
Immunodeficiency Common Variable: 5 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and Hip?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously